Altimmune, Inc.ALTNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P7
Near historical low
vs 3Y Ago
-1.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -218202.44% | +54.0% |
| 2024 | -474060.00% | -2196.6% |
| 2023 | -20642.02% | -116.6% |
| 2022 | 124130.88% | +5770.7% |
| 2021 | -2188.98% | -370.2% |
| 2020 | -465.54% | -33.8% |
| 2019 | -348.00% | +19.6% |
| 2018 | -432.88% | +99.7% |
| 2017 | -124720.16% | -59673.9% |
| 2016 | -208.65% | - |